Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

IPC is pleased to announce the release of a publication jointly produced with the International Eczema Council which explores the differences and similarities between psoriasis and atopic dermatitis.

Psoriasis and atopic dermatitis (AD) are systemic inflammatory skin disorders that share many clinical characteristics and are T-cell-driven diseases, but are marked by clear pathological differences and environmental triggers. Both conditions have significant impact on patient quality of life and, therefore, demand a thorough understanding of disease burden, associated comorbidities, and treatments. In 2016, the International Psoriasis Council and the International Eczema Council held a joint symposium entitled, “Psoriasis and Atopic Dermatitis: Two Diseases or One Spectrum?” at the European Academy of Dermatology and Venereology Congress in Vienna, Austria. The symposium debated whether the diseases are on a continuum or if the evidence presented supported the classification of each disease state as a distinct entity. Presenters provided key epidemiological and clinical differences between psoriasis and atopic dermatitis and discussed immune mechanisms and the new targeted therapies for each condition. In addition, overlapping and disparate comorbidities were examined, recognizing the need to better subclassify the diseases based on underlying immunophenotype. A session dedicated to pediatric psoriasis and atopic dermatitis highlighted important gaps in knowledge and treatment challenges.


  •  Eilis Nic Dhonncha, Department of Dermatology, St. Vincent’s University Hospital, Elm Park, Dublin 4, Ireland
  • Christopher Griffiths, Dermatology Centre, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom
  • Darren Ashcroft, School of Health Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom
  • Carsten Flohr, Unit for Population- Based Dermatology Research, St. John’s Institute of Dermatology, Guy’s and St. Thomas’ NHS Foundation Trust and King’s College London, London, United Kingdom
  • Emma Guttman-Yassky, Department of Dermatology, Icahn School of Medicine at the Mount Sinai Medical
    Center, New York, NY, United States
  • James Krueger, Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, United States
  • Thomas Bieber, Department of Dermatology and Allergy, University of Bonn, Germany
  • Matthias Augustin, Department of Dermatology, University Clinics of Hamburg, Hamburg, German
  • Eric Simpson, Department of Dermatology, Oregon Health and Science University, Portland, OR, United States
  • Joelle van der Walt, International Psoriasis Council, St. Louis, MO, United States
  • Peter CM van de Kerkhof, Department of Dermatology, Radboud University, Nijmegen, the Netherlands
  • Amy S. Paller, Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States

You can download the article HERE.

On-Demand webcasts from this program can be viewed HERE.

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.